The US vaping market has experienced significant regulatory challenges, largely due to the actions and policies of the Food and Drug Administration (FDA). These regulations have led to a complex and often chaotic environment for manufacturers, consumers, and policymakers.
This explainer provides insights into how FDA's regulatory approach has shaped the current landscape, highlighting the implications for public health and future policy directions.